T-Cell-Based Immunotherapy for Solid Tumors: Challenges, Mechanisms, and Combination Strategies
The biological mechanisms underlying CD8+ T-cell-mediated tumor killing are outlined and the major limitations faced by T cells in the treatment of solid tumors are explored, including a limited number of tumor-specific antigens, poor tumor infiltration capacity, an immunosuppressive microenvironment, metabolic stress,...